Burnout and career satisfaction in neuro-oncology: a survey of the Society for Neuro-Oncology and the European Association of Neuro-Oncology memberships.


Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
09 06 2020
Historique:
pubmed: 14 12 2019
medline: 28 4 2021
entrez: 14 12 2019
Statut: ppublish

Résumé

Professional burnout is a syndrome characterized by emotional exhaustion, depersonalization, and loss of personal achievement. Burnout is a significant issue among health care providers, and neuro-oncology providers may be at high risk. We conducted a survey to evaluate burnout and career satisfaction among those caring for patients with brain tumors, and to identify risk factors for burnout. We distributed an anonymous online survey to Society for Neuro-Oncology (SNO) members in 2016 and to European Association of Neuro-Oncology (EANO) members in 2017. The survey comprised questions about personal and professional characteristics and the validated Maslach Burnout Inventory-Human Services Survey (MBI-HSS) questionnaire. Statistical analysis included descriptive statistics, univariate and multivariate analyses, and incorporation of recently defined burnout profiles. Sixty-three percent of SNO and 61% of EANO participants were identified as having high burnout according to MBI-HSS. Among SNO participants, physicians had a lower rate of high burnout (61%) compared with allied health professionals (68%, P < 0.01) and basic scientists (83%, P < 0.01). Regarding the factors most commonly contributing to high burnout, SNO participants most commonly experienced high emotional exhaustion (48% of SNO participants vs 34% of EANO participants), whereas EANO participants most commonly experienced low personal achievement (40% vs 28%). Among both SNO and EANO participants, increasing job satisfaction reduced the likelihood of high burnout. The prevalence of burnout among neuro-oncology professionals is high and personal risk factors were identified. Burnout profiles recognize a continuum of well-being and warrant further research.

Sections du résumé

BACKGROUND
Professional burnout is a syndrome characterized by emotional exhaustion, depersonalization, and loss of personal achievement. Burnout is a significant issue among health care providers, and neuro-oncology providers may be at high risk. We conducted a survey to evaluate burnout and career satisfaction among those caring for patients with brain tumors, and to identify risk factors for burnout.
METHODS
We distributed an anonymous online survey to Society for Neuro-Oncology (SNO) members in 2016 and to European Association of Neuro-Oncology (EANO) members in 2017. The survey comprised questions about personal and professional characteristics and the validated Maslach Burnout Inventory-Human Services Survey (MBI-HSS) questionnaire. Statistical analysis included descriptive statistics, univariate and multivariate analyses, and incorporation of recently defined burnout profiles.
RESULTS
Sixty-three percent of SNO and 61% of EANO participants were identified as having high burnout according to MBI-HSS. Among SNO participants, physicians had a lower rate of high burnout (61%) compared with allied health professionals (68%, P < 0.01) and basic scientists (83%, P < 0.01). Regarding the factors most commonly contributing to high burnout, SNO participants most commonly experienced high emotional exhaustion (48% of SNO participants vs 34% of EANO participants), whereas EANO participants most commonly experienced low personal achievement (40% vs 28%). Among both SNO and EANO participants, increasing job satisfaction reduced the likelihood of high burnout.
CONCLUSIONS
The prevalence of burnout among neuro-oncology professionals is high and personal risk factors were identified. Burnout profiles recognize a continuum of well-being and warrant further research.

Identifiants

pubmed: 31832657
pii: 5674931
doi: 10.1093/neuonc/noz229
pmc: PMC7283020
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

838-850

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Neurology. 2017 Feb 21;88(8):797-808
pubmed: 28122905
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Cancer Epidemiol. 2015 Dec;39 Suppl 1:S56-66
pubmed: 26164653
Health Aff (Millwood). 2011 Feb;30(2):202-10
pubmed: 21289340
J Gen Intern Med. 2007 Nov;22(11):1544-52
pubmed: 17891503
J Clin Oncol. 2014 Mar 1;32(7):678-86
pubmed: 24470006
Fam Pract. 2008 Aug;25(4):245-65
pubmed: 18622012
Health Aff (Millwood). 2001 May-Jun;20(3):43-53
pubmed: 11585181
Sleep Health. 2015 Mar;1(1):40-43
pubmed: 29073412
Ann Oncol. 2017 Jul 1;28(7):1590-1596
pubmed: 28449049
J Neurosurg. 2015 Jul;123(1):161-73
pubmed: 25679276
JAMA. 2009 Sep 23;302(12):1284-93
pubmed: 19773563
Am J Prev Med. 2001 Jan;20(1):61-7
pubmed: 11137777
J Clin Oncol. 2012 Apr 10;30(11):1235-41
pubmed: 22412138

Auteurs

Shlomit Yust-Katz (S)

Neuro-Oncology Unit, Davidoff Cancer Center at Rabin Medical Center and Sackler Faculty of Medicine-Tel Aviv University, Israel.

Barbara O'Brien (B)

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Elizabeth Vera (E)

National Institutes of Health Neuro-Oncology Branch, Bethesda, Maryland, USA.

Alvina Acquaye (A)

National Institutes of Health Neuro-Oncology Branch, Bethesda, Maryland, USA.

Michael Weller (M)

Department of Neurology & Brain Tumor Center, University Hospital and University of Zürich, Zurich, Switzerland.

Terri Armstrong (T)

National Institutes of Health Neuro-Oncology Branch, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH